Progress in gene delivery by cationic lipids: Guanidinium-cholesterol based systems as an example

Current Drug Targets

Volumn 3, Issue 1, 2002, Pages 1-16

  Aissaoui, Abderrahim ^a   Oudrhiri, Noufissa ^a   Petit, Laure ^a   Hauchecorne, Michelle ^a   Kan, Erwan ^a   Sainlos, Matthieu ^a   Julia, Sébastien ^a   Navarro, Jean ^a   Vigneron, Jean Pierre ^a   Lehn, Jean Marie ^a   Lehn, Pierre ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMYRISTYLOXYPROPYL 3 DIMETHYL HYDROXYETHYL AMMONIUM; 1,2 DIOLEOYLOXY 3 (TRIMETHYLAMMONIO) PROPANE; 2,3 DIOLEYLOXY N [2 (SPERMINECARBOXAMIDO)ETHYL] N,N DIMETHYL 1 PROPANAMINIUM; AMMONIUM DERIVATIVE; CATION; CHOLESTEROL DERIVATIVE; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; DIOCTADECYLAMINO GLYCYLSPERMINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DNA; GUANIDINE; LIPID; LIPOFECTIN; LIPOSOME; N (3 AMINOPROPYL) N,N DIMETHYL 2,3 BIS(DODECYLOXY) 1 PROPANAMMONIUM; N [1 (2,3 DIOLEYLOXY)PROPYL] N,N,N TRIMETHYL AMMONIUM; POLYAMINE DERIVATIVE; UNCLASSIFIED DRUG;

CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HYDROPHOBICITY; MOLECULAR INTERACTION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PERMEABILITY BARRIER; REVIEW; SOMATIC CELL;

ANIMALS; CATIONS; CHOLESTEROL; DRUG DELIVERY SYSTEMS; GENE THERAPY; GUANIDINE; HUMANS; TRANSFECTION;

EID: 0036220676     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450023348082     Document Type: Review

References (134)

1. The basic science of gene transfer
2. Human gene therapy
3. Transfer of genes to humans: Early lessons and obstacles to success
4. Viral vector systems for gene therapy
5. Gene delivery systems: Bridging the gap between recombinant viruses and artificial vectors
6. Nonviral gene therapy: The promise of genes as pharmaceutical products
7. Synthetic gene transfer vectors
8. Introduction
9. Gene-based vaccines
10. Hypothesis: Naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process
11. Theory and in vivo application of electroporative gene delivery
12. Cationic liposome-mediated gene transfer
13. Polylysine-conjugate based DNA delivery
14. Polyethylenimines: A family of potent polymers for nucleic acid delivery
15. Cationic liposomes for gene therapy
16. Gene therapy for cancer : What we have done and where are we going?
17. Cancer gene therapy using nonviral vectors: Preclinical and clinical observations
18. Status of gene therapy for cystic fibrosis disease
19. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis : A double-blind placebo-controlled trial
20. Cystic fibrosis gene therapy
21. Nomenclature for synthetic gene delivery systems
22. Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes
23. Liposome-cell interactions in vitro: Effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes
24. Gene transfer into mammalian cells using synthetic cationic lipids
25. The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids
26. Membrane fusion plays an important role in gene transfection mediated by cationic liposomes
27. Liposome-mediated DNA transfer in eukaryotic cells. Dependence of the transfer efficiency upon the type of liposomes used and the host cell cycle stage
28. In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I
29. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure
30. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA
31. A novel cationic liposome reagent for efficient transfection of mammalian cells
32. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer
33. Fusion of phosphatidylethanolamine-containing liposomes and mechanism of the L alpha - HII phase transition
34. Effect of co-lipids in enhancing cationic lipid-mediated gene transfer in vivo
35. Cholesterol enhances cationic liposome-mediated DNA transfection of human respiratory epithelial cells
36. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
37. Gene transfer with a series of lipophilic DNA-binding molecules
38. Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles
39. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells
40. The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors
41. Safety and shortterm toxicity of a novel cationic lipid formulation for human gene therapy
42. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo
43. LipofectAMINE reagent: A new, higher efficiency polycationic liposome transfection reagent
44. Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity
45. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes
46. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
47. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis
48. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis
49. Cholesterol is required for the fusion of single unilamellar vesicles with Mycoplasma capricolum
50. Cationic facial amphiphiles : A promising class of transfection agents
51. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung
52. Efficient gene transfer into mammalian cells with cholesteryl-spermidine
53. Guanidinium-cholesterol cationic lipids : Novel reagents for gene transfection and perspectives for gene therapy
54. Gene delivery by guanidinium-cholesterol cationic lipids : A 1999 update
55. Guanidinium-cholesterol cationic lipids : Efficient vectors for the transfection of eukaryotic cells
56. Gene transfer by guanidinium-cholesterol cationic lipids into airway epithelial cells in vitro and in vivo
57. Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells
58. A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia
59. Submucosal glands are the predominant site of CFTR expression in the human bronchus
60. Lipidic vector systems for gene transfer
61. Polymorphism of lipids, nucleic acids and their interactions
62. Structural characteristics of supramolecular assemblies formed by guanidinium-cholesterol reagents for gene transfection
63. Cationic liposome mediated transfection
64. Mode of formation and structural features of DNA-cationic liposome complexes used for transfection
65. Complexes between cationic liposomes and DNA visualized by cryo-TEM
66. An electron microscopy study into the mechanism of gene transfer with lipopolyamines
67. The structure of DNA-liposome complexes
68. New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy
69. Virus-sized self-assembling lamellar complexes between plasmid DNA and cationic micelles promote gene transfer
70. Structure of DNA-cationic liposome complexes : DNA intercalation in multilamellar membranes in distinct interhelical packing regimes
71. Self-assembled structures of lipid/DNA nonviral gene delivery systems from synchrotron X-ray diffraction
72. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery
73. Cellular and molecular barriers to gene transfer by a cationic lipid
74. Lipidic supramolecular assemblies for gene transfer
75. Fusion of cationic liposomes with mammalian cells occurs after endocytosis
76. DNA transfection mediated by cationic liposomes containing lipopolylysine characterization and mechanism of action
77. Evidence for the role of proteoglycans in cation-mediated gene transfer
78. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection
79. Mechanism of oligonucleotide release from cationic liposomes
80. Phosphatidylethanolamine liposomes : Drug delivery, gene transfer and immunodiagnostic applications
81. Destabilization of phosphatidylethanolamine liposomes at the hexagonal phase transition temperature
82. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo : Polyethyleneimine
83. The proton sponge : A trick the viruse did not exploit
84. Polyethylenimine-mediated gene delivery : A mechanistic study
85. Adenovirus enhancement of transferring-polylysine-mediated gene delivery
86. High-efficiency receptor-mediated delivery of small and large (48 kilobases) constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles
87. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-A complexes : Toward a synthetic virus-like gene transfer vehicle
88. Adenovirus-mediated augmentation of cell transfection with unmodified plasmid vectors
89. Association of a pH-sensitive peptide with membrane vesicles : Role of amino acid sequence
90. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells
91. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells
92. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells
93. Cytoplasmic expression of a reporter gene by co-delivery of T7 RNA polymerase and T7 promoter sequence with cationic liposomes
94. A sustained cytoplasmic transgene expression system delivered by cationic liposomes
95. Metabolic instability of plasmid DNA in the cytosol : A potential barrier to gene transfer
96. Ca++-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids
97. Cationic lipid-mediated transfection of cells in culture requires mitotic activity
98. Critical assessment of the nuclear import of plasmid during cationic lipid-mediated gene transfer
99. Molecular mobility and nucleocytoplasmic flux in hepatoma cells
100. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids
101. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides
102. Import of plasmid DNA into the nucleus is sequence specific
103. The nuclear localization sequence of the SV40 T antigen promotes transgene uptake and expression in zebrafish embryo nuclei
104. Coupling of nuclear localization signals to plasmid DNA and specific interaction of the conjugates with importin alpha
105. Coupling of a targeting peptide to plasmid DNA by covalent triple helix formation
106. Gene delivery : A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus
107. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA
108. Formulations which increase the size of lipoplexes prevent serum-associated inhibition of transfection
109. Lipofection does not require the removal of serum
110. Efficient gene transfection by bisguanylated diacetylene lipid formulations
111. Activation of the complement system by synthetic DNA complexes : A potential barrier for intravenous gene delivery
112. Progress in gene delivery research and development
113. Supramolecular chemistry - Molecular information and the design of supramolecular materials
114. Sterically stabilized liposomes
115. Liposomes revisited
116. Sterically stabilized liposomes : A hypothesis on the molecular origin of the extended circulation times
117. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
118. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethyleneglycol)-phospholipid conjugates for efficient in vivo gene delivery
119. Cationic liposomes coated with polyethyleneglycol as carriers for oligonucleotides
120. Stabilized plasmid-lipid particles for regional gene therapy : Formulation and transfection properties
121. Stabilized plasmid-lipid particles : Construction and characterization
122. Sterically stabilized BGTC-based lipoplexes : Structural features and gene transfection into the mouse airways in vivo
123. Receptor-mediated gene transfer based on plasmid DNA complexes
124. Cationic liposomes enhance targeted delivery and expression of exogenous DNA mediated by N-terminal modified poly-L-lysine-antibody conjugate in mouse endothelial cells
125. Use of N-terminal modified poly-L-lysine-antobody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells
126. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands : A stage toward artificial viruses
127. Specific targeting with poly(ethyleneglycol)-modified liposomes : Coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times
128. Mammalian artificial chromosomes : A new tool for gene therapy
129. Gene transfer using purified retroviral integrase
130. Single-base conversion of mammalian genes by an RNA-DNA oligonucleotide
131. Gene correction with small DNA fragments
132. Triplex-forming molecules: From concepts to applications
133. Triplex technology takes off
134. Pharmaceutical approach to somatic gene therapy